| Literature DB >> 21422778 |
Abstract
Subcutaneous occipital nerve region stimulation is becoming an important part of the overall treatment regimen for a number of chronic headache syndromes refractory to nonsurgical, medical management. A combination of improved device technology and methodology, further understanding about appropriate indications and achievement of on-label FDA status should support continued use and success of this neuromodulation modality.Entities:
Mesh:
Year: 2011 PMID: 21422778 DOI: 10.1159/000323034
Source DB: PubMed Journal: Prog Neurol Surg ISSN: 0079-6492